Raj Shankar Ghosh
Ramesh Raj Kishore
Dr. Lucas Chan is the Chief Scientific Officer of CellVec in Singapore, a CDMO dedicated to the development and manufacture of viral vectors for human gene therapy. Lucas received his PhD at Imperial College London and was a Senior Investigator and Head of Manufacture for Advanced Therapies at King’s Health Partners in London, where he led translational development of several Advanced Cell and Gene Therapies for clinical development and established UK’s first contract manufacturing capability for clinical grade viral vectors. He is an elected Fellow of the Royal Society of Biology and an advisory member on Cell and Gene Therapy regulations in Singapore.
The BioLogistics World Asia Conference 2023 is APAC’s first and premium vein-to-vein logistics conference for biologics, therapies and vaccines. We have been connecting heads of supply chain and logistics, leaders in manufacturing, quality, warehousing, procurement and planning from Biopharma, Biologics, Vaccine Manufacturers, Cell and Gene Therapy, CAR-T and Biomedical device companies for 7 years and want you to be part of the thriving community we have built to share knowledge with your peers.
In 2023 we will be providing more value than ever for our returning and new attendees. With the CAR-T cell therapy market anticipated to experience strong growth, we will be holding mini-conferences within the event for CAR-T Logistics, as well as Vaccine Logistics, Cold Shipment Monitoring, Clinical Trial Supply Chain and more to provide in-depth and specific content tailored to each logistics team’s needs. Breakout sessions will include a Temperature-Controlled Packaging Forum, a Cold Freight Forum, and a Biologics Monitoring Forum 2023. With pavilions dedicated to markets like Korea, China, Indonesia and more we will provide regional spotlights you can’t get elsewhere.
Biologistics World Asia 2023 features market researched and tested content carefully developed to help leading organisations decide the partnerships, technology and services needed to equip the region, its life sciences companies and populations with world-class storage and distribution of vaccines, monoclonal antibodies, blood banks and other biologic products.
The 2023 Edition of the BLSA (APAC) 2023: Biopharma Logistics and SCM Awards will continue to recognize and celebrate the outstanding accomplishments and success stories of supply chain teams and their partners throughout APAC.
By 2024 experts predict that five out of the top ten best-selling drugs will require refrigerated storage and handling. Meanwhile, the biopharma industry loses approximately $35 billion annually due to failures in temperature control logistics. The popularity of highly targeted biologic drugs fuels a huge growth in the market, along with the lapsing patents of several foundational biologic drugs that promises to spur the biosimiliars market which is poised to grow by by $ 31.40 bn during 2021-2025. However the biopharma industry loses approximately $35 billion annually due to failures in temperature control logistics. Estimates suggest that up to up to 200,000 pallet shippers and 15 million cooling boxes as well as 15,000 flights will be required across the various supply chain setups.
VPs and Heads of Supply Chain, Logistics and Cold Chain Management from vaccine manufacturers, biopharma and biologics companies from APAC and the rest of the world will meet with each other as well as other technology and solution providers and global experts to evaluate the latest strategies, technologies and solutions in building a technologically enhanced high-speed and resilient vein-to-vein supply chain fit-for-purpose for the boom in temperature sensitive biologics moving through Asia’s clinical trials and markets.
Biologics Supply Chain and Technology Outlook
This section will address Singapore’s position as the regional hub for temperature sensitive products and the latest updates on APAC region’s supply chain technologies
Supply Chain Sustainability: Finding the cost-effective solution to sustainability
Sustainability has always been an important area in the supply chain to limit the environmental footprint an organisation’s distribution operations leave behind. This section will look into the integration of sustainable practices into pre-existing processes which requires intricate planning and proper cost management.
CGT & CAR-T Logistics: Managing Best Practices & Patient Centricity
CGT is a rapidly growing area in the pharmaceutical industry since it’s introduction into the APAC region. Given the cost, complexity of manufacturing CGT products and the need to tailor these products based on the patient, it is crucial for the product to be delivered to patients in the optimal condition. This section will address the strategies involved in achieving efficient distribution of CGT products in the APAC region.
Vaccine Logistics: Vaccine Rollouts & Infrastructure Challenges
Vaccine logistics is always an important topic to look into, especially for Asia due to the large population, lack of infrastructure in emerging countries and also having limited access to certain regions. This section will address the challenges faced in vaccine rollouts, digital platforms to aid vaccine distribution and infrastructure challenges faced.
Supply Chain Resilience & Security
Supply chain resilience and security plays a crucial part in the pharmaceutical industry as some products are time sensitive and some are needed to keep patients in a stable condition. Because of how unpredictable the current situation is, the local and international supply chain can be severely disrupted if supplies are not diverted or managed properly.
Warehouse Management: Operations & Inventory Optimisation
Warehousing plays an important part in the overall supply chain as it involves the storage and distribution of shipments locally and internationally. An efficient warehouse can help cut down delivery time by reducing downtime from sorting, inventory management, picking, shipment transfer, etc. It also maintains tracking and traceability of all inventory and shipments.
Roundtable Discussions: Challenges Faced in the Supply Chain
This roundtable discussion will have 5 different topics to discuss:
Table 1: Overcoming Cold Chain Logistics Challenges During Warehousing and Distribution in Developing Countries
Table 2: How Logistics can Influence Product Pricing in a Price Regulated Set-up?
Table 3: Maintaining Pharmacovigilance within a Growing Local and International Supply Chain Network
Table 4: Key Safety and Efficiency Considerations for CGT Logistics
Table 5: How to Achieve Information Transparency throughout the Supply Chain?
Operational Quality and Compliance: Maintaining Best-in-Class Operational Standards
Quality and compliance will always be important areas to look into as they serve as key guidelines for supply chain and logistics managers optimise the operations and facilities they manage. This will ensure shipments are delivered on time and kept in optimal condition at all times.
Last Mile Logistics: From Tarmac to Bicep
One of the most challenging areas within the supply chain as this is where the product gets delivered directly to the consumer, hospital or product distributor. As the next step after warehousing, it is crucial to ensure the shipments are kept in optimal condition while on the move, and also taking into account the time required to reach their destination. This section will look into the technologies and strategies that can help optimise this process.
MasterControl Inc. is the leading provider of cloud-based quality and compliance software for life sciences and other regulated industries. Our mission is the same as that of our customers – to bring life-changing products to more people sooner.
You can use the MasterControl Product Lifecycle Excellence™ platform to digitize, automate and connect quality and compliance processes at every step – from concept to commercialization. Join over 1,000 companies worldwide that rely on MasterControl solutions to achieve new levels of operational excellence across product development, clinical trials, regulatory affairs, quality management, supply chain, manufacturing and postmarket surveillance.
Learn more at www.mastercontrol.com
We deliver and implement rapid and cost-effective Biomanufacturing solutions from early phase development through scale-up to commercial manufacturing. Benefit from the most comprehensive bioprocess technology portfolio coupled with our expertise in Single-use bioprocess engineering. Our global bioprocess teams are available to discuss your process development and manufacturing requirements.
Ajinomoto Genexine is providing customers with the CELLiST™ series developed based on Ajinomoto's media manufacturing technology and know-how,
which has been researching serum-free media for over 30 years, through a number of domestic and overseas agencies. https://en.ajinomotogenexine.
“PharmNXTBiotech is a young Biotech Start-up based in Mumbai, it was established in the year 2017 with the idea of creating end-to-end bioprocess solutions and providing niche technologies to help reduce manufacturing costs for critical lifesaving drugs.
We recently inaugurated PharmNXTEkuse our brand new state-of-the-art single manufacturing facility based in Pune, which houses end-to-end solutions for the biopharma, vaccines manufacturing and containment solutions.
With the vision of “Make in India for the World,” we are ready to showcase our Xelta range of Single Use 2D, 3D bags and NXTmix Levitating mixing solutions along with our hardware technologies for downstream processing.
For containment solutions, we have our Make in India products: Flexible Isolators, Rigid Isolators as well as Powder Transfer Bags to handle potent molecules.”
Zuellig Pharma is one of the largest healthcare services groups in Asia and our purpose is to make healthcare more accessible. We provide world-class clinical trials logistics, distribution, digital and commercial services to support the growing healthcare needs in this region. The company has grown to become an over US$15 billion business covering 13 markets with over 13,000 employees, serving over 350,000 medical facilities and working with over 500 clients, including the top 20 pharmaceutical companies in the world.
Our Clinical Reach team partners with global, regional and local clients, providing end-to-end clinical supply chain solutions and have supported over 5,500 clinical trials through our regional and local depots as well as comparator and ancillary sourcing services.
AGC Biologics is a global CDMO with seven facilities worldwide providing process development and manufacturing services for protein-based biologics and advanced therapies. From development to clinical trials, to full-scale commercialization, we can help you reach your goals at any stage in the development or manufacturing process. We specialize in the following modalities and substances, mammalian and microbial-based therapeutic proteins, recombinant DNA, plasmid DNA (pDNA), viral vectors, messenger RNA (mRNA), and genetically engineered cells. Our services range from Process Development, Analytical Development, cGMP Manufacturing (both clinical and commercial), Quality Control, and Quality Assurance and Process Validation.
Since its inception, Hanbon Technology has been adhering to the original intention to provide biopharmaceutical users with drug purification equipment and services based on chromatography technology. The main products are: Biopharmaceutical downstream purification equipment, Industrial preparative liquid chromatography systems, Supercritical fluid chromatography systems, Continuous chromatography systems, Small nucleic acid synthesis and purification equipment, and can provide users with chromatography products as the core of the overall solutions and services. For more than 20 years, Hanbon has been following the wave of biopharmaceutical development, constantly developing new products and meeting the emerging needs of the market, providing R&D and production equipment for synthesis, purification and delivery of emerging small nucleic acid drugs, mRNA vaccines, cell therapy drugs, etc.
Website link: http://www.hanbon.com.cn/en/
Founded in 2000, Truking Technology Limited has become one of the major pharmaceutical equipment suppliers in the world. The
company specializes in pharmaceutical equipment and the corresponding integrated solutions, and takes the initiative to push forward
the R&D of smart pharmaceutical factory.
It is a listed A-share company with multiple wholly-owned or controlling subsidiaries, namely Germany based Romaco Group, Truking
Watertown, Sichuan Pharmaceutical Degisn Institute, Truking Feiyun, Truking Ingenuity Biotechnology, Truking Wachine, Truking
Intelligent Robot, etc.
The company has over 6500 employees around the global, a total asset of RMB 6.9 billion and annual output value of RMB 8
billion.TRUKING has two operation headquarters respectively in Changsha, China and Germany; 4 big research institutes, namely
Changsha Central Technology Research Institute, Europe Technology Research Institute, Sichuan Pharmaceutical Design Institute, and
Suzhou Technology Research Institute.
Truking has established National Enterprise Technology Center, National Innovation Center, Post-Doctoral Research Center,
Academician Expert Workstation and many more technology and innovation platforms.
To better respond to the needs of global customers,Truking has been setting up sales and service centers in many countries including
India, Italy, Greece, Russia, Uzbekistan, Turkey, Egypt, Bangladesh, Korea, Vietnam, Thailand, etc.
By August 31, 2022, Truking has submitted 4342 patent applications, and been granted with 2684 patents.
Beyond China, Truking has applied for 40PCT international patents, and been granted with 20 patents in USA, Russia, India, Korea,
Germany, Indonesia, and many more European countries. Truking also took the lead in formulating 17 national industrial product
technical standards. Our products have been exported to more than 40 counties and regions to Asia, Europe, and South America.
Cytiva is a global life sciences leader with more than 8,000 associates across 40 countries dedicated to advancing and accelerating therapeutics. As a trusted partner to customers that range in scale and scope, Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the development, manufacture, and delivery of transformative medicines to patients.
Merck, a life science leader, is a business of Merck KGgA, Darmstadt, Germany. Our products and services help you safely and efficiently develop and manufacture therapeutics.
From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere.
We are Merck, a vibrant science and technology company.
Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.
Pall Corporation provides critical filtration, separation, and purification solutions to meet the demanding needs of a broad spectrum of life sciences and industrial customers around the globe. Across 80 locations and 10,000 people worldwide, we are unified by a singular drive: to solve our customers' biggest fluid management challenges. And in doing so advance health, safety, and environmentally responsible technologies. Together, our Life Sciences and Industrial teams serve a diverse range of customers including biotechnology, pharmaceutical, medical, food and beverage, laboratory, microelectronics, aerospace, fuels, petrochemical, chemical, automotive and power generation industries. Our industry-leading technologies and solutions are at work in countless applications, protecting critical operating assets, improving product quality, safeguarding the health, and minimizing emissions and waste
For more info, please check: https://www.pall.com/en/biotech.html
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics from concept to commercialization for the benefit of patients worldwide.
With over 10,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of June 30, 2022, WuXi Biologics is supporting 534 integrated client projects, including 14 in commercial manufacturing.
WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.
GenScript ProBio is the subsidiary of GenScript Biotech Corporation, proactively providing end-to-end CDMO service from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in cell and gene therapy (CGT), vaccine, biologics discovery and antibody protein drug to accelerate drug development for customers. GenScript ProBio has established companies in the United States, the Netherlands, South Korea, Shanghai, Hong Kong, Nanjing and other places to serve global customers, and supported customers in the United States, Europe, Asia Pacific and other regions to obtain more than 30 IND approvals.
With over 50 years of experience, we understand the logistics, applications, and requirements that the specialty pharmacy industry faces. We are supporting the temperature-sensitive supply chain requirements of the COVID-19 vaccine with the industry’s broadest portfolio of single-use and reusable systems. The Utilization Review Accreditation Commission’s version 4.0 (URAC) has a mandatory requirement on component testing prior to desktop submission, and accreditation requiring qualification testing of temperature-sensitive packaging designs to be used by the dispensing specialty pharmacy. Not only will our highly trained professionals guide you through these URAC qualification processes, but our cutting-edge ISO 9001:2015, ISTA-certified, cGMP-compliant lab can do the testing for you. We offer compliance documentation for regulatory and accreditation audits, as well as PQ study kits and services. Our Rx family of shipping systems are designed specifically for last mile distribution – specialty pharmacies, mail-order pharmacies, and drug sampling programs. These solutions meet ISTA 7E summer and winter qualifications and are pre-qualified for multiple temperature ranges. Our superior pre-qualified solutions enable the pharmaceutical industry to meet their temperature, regulatory, cost-per-dose, and compliance challenges head on to get their products to those who need them most.
Peli BioThermal is the first cold chain packaging solutions provider to make available a broad and comprehensive portfolio of patented and award-winning single-use and reusable thermal protection packaging solutions for the safe transport of pharmaceuticals, clinical trials, diagnostics, tissue, vaccines and blood supplies for the life science industry.
Collaboration with our clients is the first step to ensure we provide a solution that is built around the unique and very specific needs of your temperature-sensitive payloads. Our global services network provides consultation, support, engineering and deployment for your cold chain distribution challenges wherever they exist.
Peli BioThermal designs products to ensure our customers valuable payloads are kept in perfect condition, irrespective of external temperatures and conditions. They are designed to be strong and robust, to survive the rigors of international transport. With environmental issues in mind, we ensure that our design team specify the correct materials and consider ‘end of life’ recycling for all of our ranges, whether they are single use or reusable packaging systems.
Bausch+Ströbel is a trusted and experienced supplier to the pharmaceutical industry specializing in filling and packaging systems. B+S filling and packaging lines are used worldwide to fill syringes, vials, cartridges and ampoules with high-grade liquid and powder pharmaceutical products. Applications range from cleaning and sterilization to labelling and syringe assembly. In addition to designing and building systems tailored to customer specifications, Bausch+Ströbel provide a wide range of specialized services aimed at ensuring system reliability and productivity.
Emerson is where technology and engineering come together to create solutions for the benefit of our customers, driven without compromise for a world in action. As a global innovator, Emerson has a deep legacy of solving the most complex challenges facing modern life. We combine advanced technologies, industry-leading expertise and an insatiable curiosity about the world around us to create sustainable solutions for the essential customers we serve.
Our how is complex, but our why is simple and found in our unified global Purpose: We drive innovation that makes the world healthier, safer, smarter and more sustainable. https://www.emerson.com/en-sg/
EuBiologics is developing new vaccine products with the goal of distributing safe and effective vaccines that can contribute to the promotion of global public health. In addition, it is a specialized bio company that provides CRMO (Contract Research and Manufacturing Organization) services for various biopharmaceuticals based on advanced facilities suitable for biopharmaceutical research and production, professional manpower, and rich experience in the field. Starting with Euvichol-Plus, which occupies more than 80% of the global cholera vaccine market, EuBiologics is developing new infectious disease preventive vaccines using EuIMT using the immune enhancer EcML and EuVCT technology using the recombinant protein rCRM197.
We have a cGMP-level plant (C Plant & V Plant), and we provide customized CRMO services in consideration of improving product quality and securing competitiveness for the entire production cycle of biopharmaceuticals derived from mammalian cells and microorganisms, from cell line development to GMP production.
Terumo Pharmaceutical Solutions develops patient-oriented parenteral delivery solutions for therapeutic performance and safety Globally trusted for quality and precision, Terumo Pharmaceutical Solutions offers pharmaceutical and medical device manufacturers around the world comprehensive product design and development services, for primary container, injection, infusion therapy devices, and contract development and manufacturing services (CDMO).
We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral
drug delivery. Innovation and creativity are central to our value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for
all parenteral applications. We provide sterile injectable contract development and manufacturing (CDMO) services from initial combination device design and formulation development to commercial manufacturing.
supporting better patient outcomes around the world.
We listen. We question. We deliver.
Aptamer Group develops custom affinity binders for use across the life sciences using its proprietary Optimer® platform. Optimer binders can be used as antibody alternatives to offer novel or improved solutions in downstream affinity purification and QC assays to support product release. Optimer binders are removing the barriers to innovation in the life sciences by offering simple resin compatibility, tuneable binding kinetics and high stability. https://aptamergroup.com/
JSBio is committed to becoming a world-class leader in cell culture technology and a supplier of high-quality culture medium products. It is one of the few teams in China that has a complete CMC production and operation system. Since its establishment, JSBio has always adhered to the concept of "Quality First, Customer Focused" by providing high-quality products for partners in the antibody/recombinant protein and human/veterinary vaccine industries. From basic research to commercial stages of therapeutics and vaccines, JSBio's products and services meet the highest quality and regulatory standards of the industry.
The leadership team of the JSBio are world-class culture medium manufacturers and biopharmaceutical executives. Since the establishment of the company, JSBio has served 200+ antibody/recombinant protein, human/veterinary vaccine customers, including 100+ Phase Ⅰ/II clinical projects, 30+ phase III clinical projects, and 20+ commercialization phase projects.
After ten years of development, JSBio's business has expanded to nearly 30 provinces, municipalities and autonomous regions in China, and has also extended to overseas markets such as Asia-Pacific, Europe and the United States. JSBio provides customers with high-quality culture medium products and related cell culture process services that meet multinational standards, and has also enabled the development of the biopharmaceutical industry.
ABER is the market leader in bio-capacitance sensors with unparalleled experience and expertise in the field, boasting a world class team to guide users in finding effective solutions to their process monitoring needs.
With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products.
SGS provides a comprehensive range of biosafety services such as: virology, cell and molecular biology, microbiology and TEM. Health Authorities (US FDA and the EMA), require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses and other potential contaminants. SGS ensures product safety in satisfying these regulatory requirements.
“An organization taking pride in providing engineering and construction project management consultancy (PMC) for greenfield and brownfield industrial high-tech projects. Leveraging on established network among investment agencies, industrial parks and local authorities, Medhini is well positioned to support projects from early inception such as site selection, project charter initiation and concept development. Working with various partners, we are able to initiate an early start and avoid regulatory hiccups. Added value includes Industry 4.0 implementation support, lean construction strategies, training programs with local and international universities for capacity building, media engagement in science communications among others.
We have also partnered and represent DD Enterprise for the ASEAN region. DDE is a leading enterprise engaged in designing, manufacturing, qualification and commissioning of sterile process systems. By envisioning smarter ideas, greener technologies and solutions, DDE have been redefining boundaries in the high purity business while working with bio-pharma, vaccine and sterile formulations industries for the last 25 years. DDE products offer consistent quality, reliability and repeatability as they use customized designs, state of the art design tools, best manufacturing practices, highest quality components integrated with fully automated and intelligent control systems and full cGMP documentation package.”
- The 3M biopharmaceutical business is a subset of the 3M Separation and Purification Sciences Division which utilizes cutting edge 3M material science that pushes the boundaries of purification, filtration, and separation to support production, processes that change lives, and deliver quality solutions where it matters most.
- Our biopharma and materials science expertise can help you improve in-process purity, increase the yield of your product and lower manufacturing costs – so you can focus on bringing life-saving treatments to trial and market
- Biopharmaceutical Purification | 3M
Pfanstiehl is the market leader of high purity, low endotoxin, low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all leading global biopharmaceutical companies.
Pfanstiehl was founded in 1919 and currently celebrating its 103rd anniversary year in 2022. Pfanstiehl is headquartered at Waukegan, IL, USA and has diverse global technical support team across the globe in USA, Europe & APAC.
Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s high purity, low endotoxin and low metal excipient products are known as “best in class” due to their high characterization, performance, consistency, and quality attributes.
Pfanstiehl’s excipients are critical components in the majority of the global blockbuster biopharmaceutical drugs and vaccines including majority of the Covid -19 vaccines that were administered globally.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
For more information, please visit www.thermofisher.com
Tofflon Science and Technology Group Co. Ltd. was established in 1993 and is a one-stop solution provider for bio/pharmaceutical industry. Besides being a comprehensive pharmaceutical equipment supplier, Tofflon also provides process support, core equipment, integrated systems, pharma engineering (Modular construction & Site build construction) and consumables such as media, resin and single use systems for the pharma and biotech industry around the world.
Since founded, Tofflon has supplied and supported more than 12,000 sets of equipment and systems for 3,000 pharmaceutical companies across over 50 countries and regions in the world which have been widely applied in the fields of R&D, liquid and lyo injectables, chemical API, bioengineering and pharma packaging. Tofflon has also been approved with all the international regulatory certifications like German TUV ISO9001, ISO14001, OHSAS 18001, CE, UL, ASME, PED, etc.Today, Tofflon Science and Technology Group Co. Ltd has over 5500 employees around the globe with a total asset of over 2 billion USD. The company currently has several R&D centres around the world (China, Italy and Germany) and is expanding further. Through our Technological Innovation and Development Concept: Automation, Intelligence, Modularization, Continuous Processing and System Integration, we create values for the industry and our partners: cGMP compliance, High Efficiency, Automation, Simple Interface, Cost Effective, Easy Validation, Integrated Service, and Faster Time to Market.
Eppendorf – Stimulating growth. Cultivating Solutions Efficient bioprocesses are central to the production of biopharmaceuticals, biomass, chemical building blocks, and nutritional products. Scientists from industry and academia trust Eppendorf bioprocess solutions for the cultivation of mammalian, insect, plant, and stem cells, as well as bacteria, yeasts, and fungi. Scalable systems support the upstream bioprocessing cycle from early development to scale-up to pilot-scale production, in working volumes from 65 mL to 2,400 L. Powerful hardware and software tools for process monitoring, control, and analytics, help to build process understanding and facilitate standardized process control. By utilizing the strong synergies between bioreactor technology and polymer manufacturing, Eppendorf developed a wide selection of single-use bioreactors and fermentors which complement its portfolio of glass and stainless-steel vessels. With worldwide technical and application services, clear technical documentation, and preventive maintenance services, Eppendorf ensures reliable system operation. Since 1945, the Eppendorf brand has been synonymous with customer-oriented processes and innovative products, such as laboratory devices and consumables for liquid handling, cell handling and sample handling. Today, Eppendorf and its more than 5000 employees serve as experts and advisors, using their unique knowledge and experience to support laboratories and research institutions around the world.
Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our unparalleled breadth of offerings enables our customers to commercialize their discoveries and innovations in the healthcare industry. https://www.lonza.com/
ArcticZymes Technologies ASA is born from the unique conditions in the Arctic and our innovations in Tromsø (Norway) where we have been developing and manufacturing cold-adapted enzymes for more than 30 years. We are a specialized manufacturer of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD), and biomanufacturing.
In biotherapeutics such as oncolytic virus therapy, gene therapy and vaccine production our enzymes are tailor-made for optimal performance in multiple bioprocessing and biomanufacturing workflows. Beyond the unique features, ArcticZymes Technologies is committed to providing premium and highest quality enzymes, with emphasis on robust manufacturing and reliability of supply. Our no-compromises approach to become a long-term partner with our customers has enabled countless innovations and products to successfully reach the market. Furthermore, our enzymes targeted for biotherapeutic use are specially developed to suit high quality measurements and regulatory requirements simplifying their use in GMP compliant processes.
Mitsui Chemicals is one of Japanese leading chemical companies, providing many world-class products to over 160 companies in 30 countries. Among them, InnoCell™ is one of the latest innovations for the biopharmaceutical industry. By making the base of the cell culture vessel from our material, it is possible to efficiently supply cells with approximately 200 times more oxygen than when using a conventional culture plate.
Quality Executive Partners (QxP) is a global premier consulting and training firm to the pharma, biotech, and life sciences industries. QxP's team of deeply skilled experts provide innovative and pragmatic solutions which address development, commercialization and business needs simultaneously. Our success is defined by the transfer of knowledge to our clients, enabling them to develop and commercialize quality products sustainably. QxP is the creator of the Virtuosi platform for pharmaceutical workforce education, covering aseptic processing, quality control microbiology, and cell and gene therapy manufacturing. Based on a “learn and do” methodology, Virtuosi features more than 50 on-demand e-learning video courses, and 25 virtual reality activities. Virtuosi is available in five languages.
Since 1998, Ami Polymer is in the business of Silicone Elastomeric products and also, other Polymeric components which ultimately provide solutions to Fluid Transfers, Sealing, and Contamination controls for Biopharma, Pharma, Medical, Laboratory, Food, Beverages, and Engineering sectors worldwide. We Are Experts in Silicone Tubing, Hoses & Single-Use Assemblies.
Ami Polymer is having ISO Class VII and ISO Class VIII Cleanroom facilities certified with ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 27001:2013, ISO 13485:2016. We also have a BPOG extractables program for our products for regulatory markets worldwide.
Tower Cold Chain is the essential link in the stability of the cold chain. Its innovative containers and customer services maintain the cold chain, preventing shipments being spoiled or delayed, and delivering temperature-sensitive products on time and budget.
We provide temperature-controlled solutions to the global pharmaceutical and life science industries. We have been working with businesses since 2007 to safeguard products and we understand what our customers and their markets need to create value within their supply chain. It is our vision is to be the number-one cold-chain shipping facility of choice. By collaborating with our customers, we can transport products safely, whenever and wherever they are needed.
BioPharma Asia aims to keep its readers abreast of all developments in the areas of Manufacturing, Development, Quality Assurance, Outsourcing, and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters, associated with only end-user companies. This ensures that the information will always be guaranteed to remain timely, informative and above all totally unbiased.
Cold Chain Platform (CCP) is 100% focused on cold chain and logistics in the biopharmaceutical, life science, and healthcare industries. CCP services help global companies reach the right partners and get a firm foothold in the Asia Pacific. CCP works with global organizations to help them gain access to the APAC cold chain, logistics, and pharmaceutical market through a highly targeted audience.
Counterfeit medicinal products are a threat to the health and safety of patients around the world. They range from drugs with no active ingredients to those with dangerous impurities. They can be copies of branded drugs, generic drugs or over-the-counter drugs.
Counterfeiting groups thrive in countries where the anti-counterfeiting laws are weak, the drug regulatory agencies are underfunded and under staffed, and legal sanctions are ineffective.
In assessing these illegal operations, it became clear that the counterfeiters often copied pharmaceutical products of many manufacturers and there was a need to improve information sharing.
Meeting the Challenge
In 2002, the Security Directors from fourteen major pharmaceutical companies established the Institute in Washington, D.C. Working with its members, PSI developed improved systems to identify the extent of the problem and to assist in coordinating international inquiries.
Today, PSI membership includes thirty-seven pharmaceutical manufacturers from many nations. The Institute established representational offices with staff in Miami, Florida; Singapore; and Stockholm, Sweden.